Showing 1 - 10 of 28
Siam Legal Certified as BOI LTR Visa Agency
Published on 05/09/2025
» Siam Legal International, one of Thailand’s leading legal and immigration consultancies, is proud to announce its official certification by the Board of Investment of Thailand (BOI) as a Certified Agency (CA) authorised to handle applications for the Long-Term Resident Visa, also known as the LTR Visa Thailand. This recognition positions Siam Legal as one of the few government-recognised partners for foreign nationals seeking long-term residency in Thailand.
Novo Nordisk Thailand and HSRI MoU Enhances Clinical Research Standards
Published on 02/06/2025
» The rapid advancement of medical technology is playing a vital role in enhancing the health system and quality of life for individuals in Thailand. Clinical research is essential in facilitating the development of new medications, devices, and treatment methodologies for complex and rare diseases. Reports indicate that nations such as China, the United States, various African countries, and others in Asia are significantly increasing their investments in medical research and development (R&D). Thailand has been classified as an ‘opportunity tier’, possessing a large number of patients ready for treatment. This presents researchers with numerous opportunities for trial volunteers, making Thailand more competitive compared to Europe and the US, where research costs tend to be higher.
Thammasat, Novo Nordisk Unite for Holistic Diabetes, Obesity Care
Published on 28/05/2025
» Thammasat University Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), announced a collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity Beat Diabetes” at the Thammasat University Hospital. The public-private partnership aims to enhance holistic patient care and expand equitable access for all.
Novo Nordisk Launches Campaign to Tackle Obesity
Published on 20/05/2025
» Novo Nordisk Pharma (Thailand) Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the “From My Weight to My Heart” campaign, aimed at reducing the risk of cardiovascular diseases and non-communicable diseases (NCDs)—key global health challenges. The campaign debuted with an inspirational panel featuring leading public figures.
Novo Nordisk, Nanyang Launch Shoes for Haemophilia Awareness
Published on 08/05/2025
» Bangkok, Thailand – 6 May 2025 – Novo Nordisk Pharma (Thailand) Ltd. (Novo Nordisk), a global healthcare company committed to driving change in chronic diseases, has announced the delivery of unique shoes, produced in collaboration with renowned Thai shoe manufacturer Nanyang, to the Thai Haemophilia Patient Club. The collaboration aims to enhance awareness of haemophilia in Thailand, underscoring the message of equitable access to healthcare.
Novo Nordisk Leads Danish-Thai Forum on Obesity Solutions
Published on 08/05/2025
» The Royal Danish Embassy in Thailand, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), organised the first Danish-Thai Obesity Policy Forum, bringing together top policymakers, healthcare professionals and industry representatives to discuss challenges arising from the growing prevalence of obesity and its socio-economic impacts in Thailand. The forum, titled “Obesity – A National Threat to Health and Wealth, Act Now for Our Future Generations”, featured remarks from decision-makers and a panel discussion.
Chulalongkorn, Novo Nordisk Partner to Tackle Obesity
Published on 05/04/2025
» Bangkok, April 2025 – Chulalongkorn University, in collaboration with Novo Nordisk Pharma (Thailand) Ltd., has officially launched “Chulalongkorn x Novo Nordisk: Enhancing Obesity Management through Innovative Collaboration” at the Rattanawithayapat Building, King Chulalongkorn Memorial Hospital. This initiative marks a significant public-private partnership aimed at improving access to reliable obesity information and promoting more effective management through digital engagement.
Novo Nordisk Launches Blockchain to Fight Counterfeit Drugs
Published on 27/03/2025
» Novo Nordisk Thailand has announced the successful implementation of a blockchain-based traceability solution to verify the authenticity of Ozempic® across the supply chain, addressing the growing threat of counterfeit medicines and enhancing patient safety.
Novo Nordisk and Bangkok Unite for a Healthier Future
Published on 17/03/2025
» To mark World Obesity Day 2025, Novo Nordisk participated in the Chula Obesity Day event, organised by Chulalongkorn University. As part of the session “How Cities and Partnerships Drive a Sustainable Future Against Obesity,” which aligned with the global theme “Changing Systems, Healthier Lives,” Thai authorities—including the Thai Health Promotion Foundation and the Bangkok Metropolitan Administration (BMA)—gathered to discuss the growing obesity crisis in Thailand and the role of public-private partnerships in addressing it.
Transforming Diabetes Care: Thai-Danish Collaboration Leads the Way
Published on 24/01/2025
» The Danish Embassy in Thailand, under the leadership of H.E. Mr. Danny Annan, Ambassador of Denmark to Thailand and Cambodia, hosted a pivotal session that marked a significant milestone in international healthcare collaboration. The event, following a visit by a Thai health delegation to Denmark from November 19-21, 2024, brought together key stakeholders to explore innovative strategies for diabetes management and public health transformation with eleven Thai government officials embarked on this journey with a clear mission: to explore cutting-edge diabetes management strategies, innovative health reimbursement models, and the potential of public-private partnerships in healthcare.